Triple-negative breast cancer (TNBC), which is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, accounts for 15–20% of all breast cancers. This evidence concerns the gene PGR and breast carcinoma.